Next-Gen Biomarkers Fueling Rapid Growth in MicroRNA Industry

[thorat Ketan]

The global MicroRNA (miRNA) Market Share, valued at USD 1.3 billion in 2023, is projected to reach USD 7.7 billion by 2032, expanding at an extraordinary CAGR of 21.1% from 2024 to 2032, according to recent market analysis. This exponential growth is attributed to the rising role of miRNA in diagnostics, therapeutics, and drug discovery, supported by extensive investments in molecular biology and precision medicine.

MicroRNAs, small non-coding RNA molecules with the ability to regulate gene expression, have become crucial biomarkers and therapeutic targets across multiple disease domains—especially cancer, cardiovascular disorders, and neurodegenerative conditions. Their specificity, stability in biofluids, and regulatory potential are propelling a revolution in modern biomedical research and clinical application.

Get Free Sample Report on MicroRNA Market  

https://www.snsinsider.com/sample-request/3143

Market Drivers

1. Expanding Role of miRNA in Disease Diagnosis and Prognosis

The use of microRNAs as biomarkers for early diagnosis and prognosis of diseases is transforming diagnostic workflows. With increasing demand for non-invasive and highly accurate biomarkers, miRNA profiling is rapidly being integrated into routine diagnostic platforms, particularly in oncology, cardiovascular diseases, and infectious disease testing.

2. Growing Applications in Cancer Research

Cancer diagnostics and therapeutics represent the largest application area for microRNAs. Abnormal miRNA expression profiles are strongly associated with tumorigenesis, progression, and metastasis. This has led to a surge in miRNA-based assays and tests for various cancers, enabling better disease stratification and targeted treatment planning.

3. Investment Surge in RNA-based Therapeutics

Biopharmaceutical companies and research institutions are making significant investments in RNA-based drug development. miRNA therapeutics, which can silence or activate specific gene expressions, offer a new avenue for treating previously untreatable genetic and chronic diseases. Several miRNA-based drug candidates are currently under preclinical and clinical trials.

4. Technological Advancements in miRNA Detection

Innovations in molecular diagnostics—such as qRT-PCR, next-generation sequencing (NGS), and microarray technologies—have significantly enhanced the sensitivity, speed, and accuracy of miRNA detection. This has broadened their utility across research and clinical laboratories.

5. Rising Government and Private Sector Funding

Governments and funding agencies around the world are prioritizing molecular research initiatives. Programs supporting biomarker discovery, RNA research, and personalized medicine are creating favorable conditions for the microRNA market to thrive.

Key Market Segmentation

By Products & Services

• Services
  1. Type
     1. Isolation & Purification
     2. miRNA cDNA Synthesis
     3. Profiling, Localization, & Quantification
     4. Functional Analysis
     5. Others
  2. Specimen
     1. Whole Blood
     2. Serum
     3. Plasma
     4. FFPE
     5. Fresh Frozen Tissue
     6. Others

• Products

1. Instruments
   1. Technology
      1. Real Time PCR
      2. Microarray
      3. NGS
      4. Others
   2. Workflow
      1. Isolation & Purification
      2. miRNA cDNA Synthesis
      3. Profiling, Localization, & Quantification
      4. Functional Analysis & Others
      5. Others
2. Consumables
   1. Specimens
      1. Whole Blood
      2. Serum
      3. Plasma
      4. FFPE
      5. Fresh Frozen Tissue
      6. Others
   2. Workflow
      1. Isolation & Purification
      2. miRNA cDNA Synthesis
      3. Profiling, Localization, & Quantification
      4. Functional Analysis
      5. Others

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End Users

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

Key Players

• Thermo Fisher Scientific, Inc.
• QIAGEN
• New England Biolabs
• Quantabio
• Horizon Discovery Group plc.
• NanoString Technologies, Inc.
• Merck KGaA
• Takara Bio, Inc.
• LGC Limited
• BioGenex
• GeneCopoeia, Inc.
• New England Biolabs
• BioVendor
• Heim Biotek
• SeqMatic LLC
• Miltenyi Biotec
• Sistemic Scotland Limited
• Biodynamics Laboratory Inc.
• OriGene Tec
• Synlogic

Strategic Developments

• March 2024: Qiagen launched a new miRNA extraction kit optimized for liquid biopsy samples, enhancing early cancer detection capabilities.
• October 2023: Thermo Fisher Scientific announced a partnership with a leading research institute to develop AI-driven miRNA data analysis tools.
• July 2023: Bio-Rad Laboratories expanded its digital PCR platform to include high-sensitivity miRNA quantification, targeting the oncology segment.

Opportunities and Challenges

Opportunities

• Expansion of liquid biopsy techniques
• Growing adoption in companion diagnostics
• AI and machine learning integration for miRNA data analytics
• Expansion into veterinary and agricultural applications

Challenges

• Standardization issues across platforms and protocols
• High cost of miRNA-based technologies
• Regulatory complexities for clinical validation
• Data analysis and interpretation hurdles due to the small size and complexity of miRNAs

Future Outlook

The future of the microRNA market looks extremely promising, with groundbreaking advancements expected in both research and clinical settings. With the rise of precision medicine and molecular diagnostics, miRNAs are set to play a pivotal role in shaping next-generation healthcare solutions.

As technology matures and regulatory pathways become clearer, miRNA-based diagnostic kits and therapeutic agents are anticipated to enter mainstream healthcare. The market’s evolution from bench research to bedside application will be critical in the years ahead.

The journey from USD 1.3 billion in 2023 to USD 7.7 billion by 2032 represents not just financial growth, but also a significant leap in translational science, personalized medicine, and healthcare innovation.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: [phone] (US) | [phone] (UK)